Cancer

Items 11-20 of 27

Page
per page
Set Descending Direction
  1. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-1) (preservative free)
    AG-27B-0001PF
    AG-27B-0001PF-C100100 µg
    CHF 455.00
    AG-27B-0001PF-C500500 µg
    CHF 1'140.00
    Binding of APRIL (mouse) to BCMA is inhibited by anti-APRIL (mouse), mAb (rec.) (blocking) (APRY-1-1) (Prod. No. AG-27B-0001).
BCMA:Fc was coated on an ELISA plate at 1μg /ml. anti-APRIL (mouse) mAb (rec.) (blocking) (APRY-1-1) or an unrelated mA
  2. anti-APRIL (mouse), mAb (rec.) (blocking) (Apry-1-3)
    AG-27B-0017
    AG-27B-0017-C100100 µg
    CHF 455.00
  3. anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
    AG-20B-6001YPF
    AG-20B-6001YPF-C100100 µg
    CHF 290.00
    AG-20B-6001YPF-C500500 µg
    CHF 730.00
    Replaces AG-20B-6001PF
    anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
  4. anti-Lewisy/b hapten (human), mAb (SC104) (preservative free)
    AG-20B-6002PF
    AG-20B-6002PF-C100100 µg
    CHF 470.00
  5. anti-Netrin-1 (human), mAb (rec.) (blocking) (2F5) (preservative-free)
    AG-27B-0018PF
    AG-27B-0018PF-C100100 µg
    CHF 420.00
    AG-27B-0018PF-C500500 µg
    CHF 1'140.00
    Schematic antibody structure of the recombinant antibody anti-Netrin-1 (human), mAb (rec.) (blocking) (2F5) (Prod. No. AG-27B-0018PF). The single chain variable human fragment (ScFv) selected by antibody phage display technology and specific to the antige
  6. anti-PD-1 (mouse), mAb (blocking) (1H10)
    AG-20B-0075
    AG-20B-0075-C100100 µg
    CHF 230.00
    anti-BAFF (mouse), mAb (Sandy-2) (Prod. No. AG-20B-0063) blocks the action of endogenous BAFF in vivo.  Method: Wild type C57BL/6 mice were treated at day 0 (single administration) with monoclonal antibody anti-BAFF (mouse), mAb (Sandy
  7. anti-PD-1 (mouse), mAb (blocking) (1H10) (preservative free)
    AG-20B-0075PF
    AG-20B-0075PF-C100100 µg
    CHF 230.00
    AG-20B-0075PF-C500500 µg
    CHF 400.00
    AG-20B-0075PF-M0022 mg
    CHF 590.00
    anti-BAFF (mouse), mAb (Sandy-2) (Prod. No. AG-20B-0063) blocks the action of endogenous BAFF in vivo.  Method: Wild type C57BL/6 mice were treated at day 0 (single administration) with monoclonal antibody anti-BAFF (mouse), mAb (Sandy
  8. anti-Periostin, mAb (blocking) (OC-20) (preservative free)
    AG-20B-6000YPF
    AG-20B-6000YPF-C100100 µg
    CHF 470.00
    AG-20B-6000YPF-C500500 µg
    CHF 1'900.00

    Replaces AG-20B-6000PF

    anti-Periostin, mAb (blocking) (OC-20) (preservative free)
  9. anti-Sortilin (human), mAb (rec.) (blocking) (preservative free) [Latozinemab]
    AG-27B-7000PF
    AG-27B-7000PF-C100100 µg
    CHF 420.00
    AG-27B-7000PF-C500500 µg
    CHF 1'600.00
    anti-Sortilin (human), mAb (rec.) (blocking) (preservative free) [Latozinemab]

Items 11-20 of 27

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.